Recommendation 1. Initial investigation for potential liver disease should include bilirubin, albumin, alanine aminotransferase (ALT), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT) and a full blood count. (Recommendation Strong, Certainty Moderate)
Recommendation 2. Laboratories should use methodologies that incorporate pyridoxal 5′-phosphate (PLP) supplementation to ensure that accurate results for ALT and aspartate aminotransferase (AST) are obtained. (Recommendation Strong, Certainty Moderate)
Recommendation 3. Laboratory IT systems should have the ability to add reflex tests to initial samples or develop liver function testing profiles (eg, Fibrosis-4 (FIB-4) score, intelligent Liver Function Testing (iLFT)) to facilitate the diagnosis/exclusion of liver disease without the need for additional phlebotomy sessions. (Recommendation Strong, Certainty High)
Recommendation 4. The following groups should have standard liver blood tests: people with non-specific symptoms; clinical or imaging features suggestive of chronic liver disease; risk factors for liver disease or viral hepatitis; people taking hepatotoxic drugs; and…